Cardiac Monitoring & Cardiac Rhythm Management Devices Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Cardiac Monitoring & Cardiac Rhythm Management Devices Market

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size by Monitoring (ECG (Holter, ILR), COM), Rhythm Management (Defibrillators (ICD, AED), Pacemaker), Application (Heart Failure, Arrhythmias, MI), Procedure (Invasive) & Region - Global Forecast to 2029

FREE BROCHURE FREE SAMPLE REPORT
Report Code: MD 1038 May, 2024, by marketsandmarkets.com

The size of global cardiac monitoring & cardiac rhythm management devices market in terms of revenue was estimated to be worth $21.3 billion in 2024 and is poised to reach $26.4 billion by 2029, growing at a CAGR of 4.3% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

The expansion of this market is majorly due to presence of Favorable regulatory frameworks and reimbursement policies for cardiac monitoring and rhythm management devices incentivize healthcare providers to invest in these technologies and integrate them into clinical practice. However, Integration and interoperability issues between different cardiac monitoring devices and electronic health record systems may hinder seamless data exchange and care coordination.

Attractive Opportunities in the Cardiac Monitoring & Cardiac Rhythm Management Devices Market

Cardiac Monitoring & Cardiac Rhythm Management Devices Market

To know about the assumptions considered for the study, Request for Free Sample Report

Cardiac Monitoring & Cardiac Rhythm Management Devices Market

Global Cardiac Monitoring & Cardiac Rhythm Management Market Dynamics

Driver: Growing Geriatric Population and Subsequent Increase In CVD Prevalence

The global population is aging, with a significant portion of the population being aged 65 and above. Elderly individuals are more prone to developing cardiovascular diseases due to factors such as age-related changes in the cardiovascular system, comorbidities, and lifestyle factors. Likewise, Aging is associated with an increased risk of cardiovascular diseases such as coronary artery disease, heart failure, atrial fibrillation, and arrhythmias. As the geriatric population grows, so does the prevalence of these cardiovascular conditions, driving the demand for cardiac monitoring and rhythm management devices.

The geriatric population is at a higher risk of CVDs, lung diseases, stroke, diabetes, and chronic kidney disease. Most of these diseases require the continuous monitoring of vital signs, such as blood pressure, temperature, respiratory rate, and heart rate and rhythm. Considering this, cardiac monitoring devices, with other parameters (such as blood pressure and pulse rate), are rapidly being adopted globally for personal and hospital care.

Per a UN report, the global population aged 60 years and above was 761 million in 2021 and is expected to rise to 1.6 billion in 2050. According to World Population Prospects (2019 Revision), by 2050, one in four persons residing in Europe and Northern America could be 65 years or above. Furthermore, according to the American Heart Association (AHA) 2020, the geriatric population in the US (individuals aged 65 and over) increased from 40 million in 2007 to 51 million in 2017; this is projected to reach 95 million in 2060. Given this dramatic growth in the aged population, age-related heart failure (HF) is expected to increase significantly.

The expanding population base of geriatric patients and the rising prevalence rate of various CVDs are expected to drive market growth in the coming years.

RESTRAINT: High device cost

The high cost of CM & CRM devices is a major factor restraining market growth, especially in developing countries with inadequate reimbursement policies. Pacemaker implantation surgery in India costs a fraction of the same in the US and other developed countries. The average cost of pacemaker implantation surgery in India is USD 3,000 to USD 5,500. The high cost of cardiac monitoring and rhythm management devices can impose a significant financial burden on patients, especially those with limited financial resources or inadequate insurance coverage. Patients may hesitate to invest in expensive devices, leading to delayed or deferred treatment and monitoring, which can negatively impact their health outcomes.S imilarly, The high device cost can create affordability barriers for patients who require ongoing monitoring and management of cardiovascular conditions, such as heart failure, arrhythmias, and coronary artery disease. Patients may forego recommended cardiac monitoring or opt for less expensive alternatives, compromising the quality and effectiveness of their care.

Opportunity: Wearable Technologies and Mobile Health (MHealth) Applications

The proliferation of wearable technologies, such as smartwatches, fitness trackers, and mobile health applications, offers new opportunities for continuous cardiac monitoring and personalized health management. Wearable devices equipped with built-in sensors can track vital signs, heart rate variability, and activity levels, providing valuable data for assessing cardiovascular health and detecting early signs of cardiac abnormalities. Integrating wearable technologies with cardiac monitoring devices and mHealth platforms enables seamless data transmission, real-time alerts, and personalized interventions, empowering individuals to take proactive steps towards improving their cardiac health.

Challenge: Dearth of Skilled Professionals

In most countries, there is a shortage of physicians and healthcare professionals with the expertise and know-how to handle cardiac monitoring devices, such as ECG devices, new cardiac pacemakers, and defibrillators implanted in patients with heart rhythm ailments or congestive heart failure. According to a survey on the latest business conditions conducted by the National Association for Business Economics (NABE), 35% of participants reported a shortage of skilled professionals in the US. According to the Association of American Medical Colleges (AAMC), the US will face a shortage of approximately 124,000 physicians by 2034. This shortage of skilled professionals and physicians in healthcare will have an impact on the cardiac monitoring and cardiac rhythm management devices market

Ecosystem Analysis of Cardiac Monitoring & Cardiac Rhythm Management Devices Market

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Ecosystem

Source: MarketsandMarkets Analysis

An ecosystem analysis of the cardiac monitoring and cardiac rhythm management devices market involves examining the interconnected network of stakeholders, technologies, regulations, and market dynamics that shape the industry. It provides insights into the complex interplay between stakeholders, technologies, regulations, and market dynamics, guiding strategic decision-making and innovation within the industry.

Transvenous Implantable Cardioverter Defibrillators (T-ICDs in cardiac rhythm management devices market’s segment of the cardiac monitoring & cardiac rhythm management devices industry to witness the second highest shares during the forecast period.

Based on the Type, the global cardiac monitoring & cardiac rhythm management devices market is segmented into Transvenous Implantable Cardioverter Defibrillators (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators. Targeted Diseases Transvenous Implantable Cardioverter Defibrillators (T-ICDs),  segment is expected to witness the second highest shares. The growth of this market is driven by due to its wide applications such as T-ICDs have been in clinical use for a longer period and have a more extensive clinical evidence base compared to S-ICDs, moreover, T-ICDs have demonstrated effectiveness in terminating life-threatening ventricular arrhythmias and preventing sudden cardiac death in various patient populations, including those with structural heart disease, coronary artery disease, and inherited arrhythmia syndromes.Morover, overall cost-effectiveness of T-ICDs may be favorable when considering long-term outcomes.

Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators segment of the cardiac monitoring & cardiac rhythm management devices industry to witness the highest shares during the forecast period.

Based on the Type, cardiac monitoring & cardiac rhythm management devices market is classified into Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators, Dual-Chamber Implantable Cardioverter Defibrillators, Single-Chamber Implantable Cardioverter Defibrillators. The Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators segment is forecasted to drive the highest shares of cardiac rhythm management devices Market. This is due to the BiV ICDs combine the functions of ICDs with cardiac resynchronization therapy (CRT), which is beneficial for patients with heart failure and ventricular dyssynchrony. Moreover, efficacy of BiV ICDs compared to single or dual-chamber ICDs in reducing mortality, hospitalizations, and heart failure symptoms in patients with heart failure and reduced ejection fraction. BiV ICDs have been shown to improve left ventricular function, reverse ventricular remodeling, and reduce the risk of arrhythmic events and sudden cardiac death.

North America dominates the global cardiac monitoring & cardiac rhythm management devices industry

Based on the region, the cardiac monitoring & cardiac rhythm management devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the cardiac monitoring & cardiac rhythm management devices market. Growth in the North American market is mainly driven by the factors such as Several leading medical device manufacturers based in North America, particularly in the United States, have a strong presence in the global healthcare market. These companies often have well-established distribution networks, brand recognition, and innovative product offerings that enable them to capture market share likewise, North American companies are often at the forefront of technological innovation in the healthcare industry. They invest heavily in research and development to develop advanced cardiac monitoring and rhythm management devices with cutting-edge features and functionalities, appealing to healthcare providers and patients.

Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Some of the players operating in North American market are Abbott Laboratories (US), Boston Scientific Corporation (US), GE HealthCare (US), Baxter.(US), ACS Diagnostics.(US), BTL (US), and Nasiff Associates Inc. (US)

Scope of the Cardiac Monitoring & Cardiac Rhythm Management Devices Industry

Report Metric

Details

Market Revenue Size in 2024

$21.3 billion

Projected Revenue Size by 2029

$26.4 billion

Industry Growth Rate

Poised to Grow at a CAGR of 4.3%

Market Driver

Growing Geriatric Population and Subsequent Increase In CVD Prevalence

Market Opportunity

Wearable Technologies and Mobile Health (MHealth) Applications

This research report categorizes the cardiac monitoring & cardiac rhythm management devices market to forecast revenue and analyze trends in each of the following submarkets:

By Region
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
By Type
  • ECG Devices
    • Resting ECG Devices
    • Stress ECG Devices
    • Holter Monitors
    • Event Monitors
  • Event Monitors by Type
    • Loop memory monitor
    • Patch recorders.
    • Symptom event monitor
    • Implanted loop recorders
  • Event Monitors by Technology
    • Patient Activated
    • Auto Detected
  • Smart ECG Monitors
  • Mobile Cardiac Telemetry Devices
  • Cardiac Output Monitoring Devices
By Type
  • Defibrillators
    • Implantable Cardioverter Defibrillators
      • Transvenous Implantable Cardioverter Defibrillators (T-ICDs)
        • Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators
        • Dual-Chamber Implantable Cardioverter Defibrillators
        • Single-Chamber Implantable Cardioverter Defibrillators
      • Subcutaneous Implantable Cardioverter Defibrillators
    • External Defibrillators
      • Automated External Defibrillators
        • Semi-Automated External Defibrillators
        • Fully Automated External Defibrillators
    • Manual External Defibrillators
    • Wearable Cardioverter Defibrillators
  • Pacemakers
  • Pacemakers Market, By Implantability
    • Implantable Pacemakers
    • External Pacemakers
  • Pacemakers Market, By Type
    • Dual-Chamber Pacemakers
    • Single-Chamber Pacemakers
  • Biventricular/Crt Pacemakers
By Application
  • Arrhythmias
  • Myocardial Infarction
  • Heart Failure
  • Other
By Procedure
  • Invasive
  • Non-invasive
Cardiac Monitoring & Cardiac Rhythm Management Devices By End User
  • Hospitals
  • Clinics, Cardiac Centers and Ambulatory Surgery Centers
  • Other End Users

Recent Developments of Cardiac Monitoring & Cardiac Rhythm Management Devices Industry:

  • In 2023, Abbott launched Asert-IQ, a Bluetooth-enabled insertable cardiac monitor for the long-term monitoring of heart rhythms.
  • In 2023, Boston Scientific received FDA clearance and launched the next-generation LUX-Dx II/II+ ICM system for long-term monitoring of arrhythmias.
  • In 2021, Baxter International announced the acquisition of Hillrom. Baxter paid USD 156.00 in cash for each outstanding share of Hillrom common stock for a purchase price of USD 10.5 billion (based on Hillrom share counts at closing).{deal size USD 12.5 billion}

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 48)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 REGIONS COVERED
           1.3.3 YEARS CONSIDERED
           1.3.4 CURRENCY CONSIDERED
    1.4 STAKEHOLDERS
    1.5 SUMMARY OF CHANGES 
           1.5.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 53)
    2.1 RESEARCH DATA 
    2.2 RESEARCH APPROACH 
          FIGURE 1 RESEARCH DESIGN
           2.2.1 SECONDARY DATA
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Key industry insights
                    2.2.2.3 Breakdown of primary interviews
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS
    2.3 MARKET SIZE ESTIMATION 
           2.3.1 BOTTOM-UP APPROACH
                    FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
           2.3.2 GROWTH FORECAST
                    FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
           2.3.3 TOP-DOWN APPROACH
                    FIGURE 7 TOP-DOWN APPROACH
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 8 MARKET DATA TRIANGULATION METHODOLOGY
    2.5 ASSUMPTIONS 
          FIGURE 9 ASSUMPTIONS FOR RESEARCH
    2.6 LIMITATIONS 
    2.7 RISK ASSESSMENT 
          TABLE 1 RISK ASSESSMENT: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
    2.8 RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 65)
    FIGURE 10 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
    FIGURE 11 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
    FIGURE 12 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    FIGURE 13 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2024 VS. 2029 (USD MILLION)
    FIGURE 14 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
    FIGURE 15 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
 
4 PREMIUM INSIGHTS (Page No. - 69)
    4.1 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OVERVIEW 
          FIGURE 16 GROWING PREVALENCE OF GENETIC DISORDERS TO DRIVE MARKET
    4.2 ECG DEVICES MARKET, BY TYPE, 2024–2029 
          FIGURE 17 RESTING ECG DEVICES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
    4.3 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER (2024) 
          FIGURE 18 US AND INVASIVE PROCEDURES TO DOMINATE NORTH AMERICAN MARKET IN 2024
    4.4 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 19 ASIAN COUNTRIES TO REGISTER HIGHER GROWTH FROM 2024 TO 2029
 
5 MARKET OVERVIEW (Page No. - 72)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 20 CM & CRM DEVICES MARKET: DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
           5.2.1 DRIVERS
                    5.2.1.1 Growing geriatric population and subsequent increase in CVD prevalence
                                FIGURE 21 HEART AND CIRCULATORY DISEASE PREVALENCE: GLOBAL STATISTICS (2021)
                    5.2.1.2 Availability of reimbursement for CM & CRM devices
                                TABLE 2 CPT CODES FOR CM & CRM DEVICES, 2020
                    5.2.1.3 Rising awareness and prevention initiatives
                    5.2.1.4 Increasing investments, funds, and grants for research
                    5.2.1.5 Growing preference for wearable cardiac devices
           5.2.2 RESTRAINTS
                    5.2.2.1 High device costs
                    5.2.2.2 Adverse effects and associated complications
                                TABLE 3 POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH DIFFERENT DEVICES
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Measures to reduce infections caused by CIEDs
                    5.2.3.2 Untapped emerging markets
           5.2.4 CHALLENGES
                    5.2.4.1 Risk of associated cybersecurity vulnerabilities
                    5.2.4.2 Frequent product recalls
                                TABLE 4 KEY PRODUCT RECALLS
                    5.2.4.3 Stringent regulatory requirements delaying the approval of cardiac devices
                    5.2.4.4 Dearth of skilled professionals
    5.3 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 5 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.3.1 THREAT OF NEW ENTRANTS
           5.3.2 THREAT OF SUBSTITUTES
           5.3.3 BARGAINING POWER OF BUYERS
           5.3.4 BARGAINING POWER OF SUPPLIERS
           5.3.5 INTENSITY OF COMPETITIVE RIVALRY
    5.4 ECOSYSTEM/MARKET MAP 
          FIGURE 22 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: ECOSYSTEM
          TABLE 6 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET: ROLE IN ECOSYSTEM
          FIGURE 23 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET: KEY PLAYERS
    5.5 VALUE CHAIN ANALYSIS 
          FIGURE 24 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASE
    5.6 SUPPLY CHAIN ANALYSIS 
          FIGURE 25 DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES
    5.7 REGULATORY LANDSCAPE 
           5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.7.2 NORTH AMERICA
                    5.7.2.1 US
                    5.7.2.2 Canada
           5.7.3 EUROPE
           5.7.4 ASIA PACIFIC
                    5.7.4.1 China
                    5.7.4.2 Japan
                    5.7.4.3 India
           5.7.5 LATIN AMERICA
                    5.7.5.1 Brazil
                    5.7.5.2 Mexico
           5.7.6 MIDDLE EAST
           5.7.7 AFRICA
    5.8 PRICING ANALYSIS 
           5.8.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
                    TABLE 12 AVERAGE SELLING PRICE OF HOLTER ECG MONITORS
                    TABLE 13 AVERAGE SELLING PRICE OF DEFIBRILLATORS
    5.9 TRADE ANALYSIS 
          TABLE 14 IMPORT DATA FOR HS CODE 901819-COMPLIANT PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION)
          TABLE 15 EXPORT DATA FOR HS CODE 901819-COMPLIANT PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION)
    5.10 TECHNOLOGY ANALYSIS 
           5.10.1 HOLTER MONITOR
           5.10.2 DEFIBRILLATORS
    5.11 PATENT ANALYSIS 
           FIGURE 26 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: TOP 10 COMPANIES (APPLICATIONS/OWNERS)
    5.12 KEY CONFERENCES AND EVENTS, 2024–2025 
           TABLE 16 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: LIST OF CONFERENCES AND EVENTS
    5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
           FIGURE 27 REVENUE SHIFT IN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO END USERS
                     TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO END USERS (%)
           5.14.2 BUYING CRITERIA
                     FIGURE 29 KEY BUYING CRITERIA FOR TOP TWO END USERS
                     TABLE 18 KEY BUYING CRITERIA FOR TOP TWO END USERS
 
6 CARDIAC MONITORING DEVICES MARKET, BY TYPE (Page No. - 96)
    6.1 INTRODUCTION 
          TABLE 19 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
    6.2 ECG DEVICES 
          TABLE 20 ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 21 ECG DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.1 RESTING ECG DEVICES
                    6.2.1.1 Low cost, ease of use, and simplicity to drive adoption
                                TABLE 22 RESTING ECG DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.2 STRESS ECG DEVICES
                    6.2.2.1 High device cost to affect adoption rate
                                TABLE 23 STRESS ECG DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.3 HOLTER MONITORS
                    6.2.3.1 Short duration of monitoring to restrain adoption
                                TABLE 24 HOLTER MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.4 EVENT MONITORS
                    TABLE 25 EVENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    6.2.4.1 Event monitors market, by type
                                TABLE 26 EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                               6.2.4.1.1 Loop memory monitors
                                             6.2.4.1.1.1 Large storage capacity to support use in long-term monitoring
                                                              TABLE 27 LOOP MEMORY MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                               6.2.4.1.2 Patch recorders
                                             6.2.4.1.2.1 Patch recorders to play valuable role in diagnosing and managing cardiac conditions
                                                              TABLE 28 PATCH RECORDER EVENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                               6.2.4.1.3 Symptom event monitors
                                             6.2.4.1.3.1 Ease of use and on-demand recording to drive adoption
                                                              TABLE 29 SYMPTOM EVENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                               6.2.4.1.4 Implanted loop recorders
                                             6.2.4.1.4.1 High cost and limited applications to hinder demand growth
                                                              TABLE 30 IMPLANTED LOOP RECORDERS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    6.2.4.2 Event monitors market, by technology
                                TABLE 31 EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                               6.2.4.2.1 Patient-activated event monitors
                                             6.2.4.2.1.1 Need for manual activation to slow market growth
                                                              TABLE 32 PATIENT-ACTIVATED EVENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                               6.2.4.2.2 Auto-detect event monitors
                                             6.2.4.2.2.1 Auto-detect monitors to show higher CAGR in event monitors segment
                                                              TABLE 33 AUTO-DETECT EVENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.5 SMART ECG MONITORS
                    6.2.5.1 Lack of data security to hinder market growth
                                TABLE 34 INDICATIVE LIST OF SMART ECG MONITORS
                                TABLE 35 SMART ECG MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.3 MCT DEVICES 
           6.3.1 INCREASING DEMAND FOR CARDIAC MONITORING SOLUTIONS IN HOME CARE SETTINGS TO PROPEL MARKET GROWTH
                    TABLE 36 MCT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.4 COM DEVICES 
           6.4.1 RISING NUMBER OF CARDIAC SURGERIES TO DRIVE DEMAND FOR COM DEVICES
                    TABLE 37 TYPES OF COM DEVICES
                    TABLE 38 COM DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
7 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE (Page No. - 109)
    7.1 INTRODUCTION 
          TABLE 39 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 40 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2023–2029 (UNITS)
    7.2 DEFIBRILLATORS 
          TABLE 41 DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 42 DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
           7.2.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
                    TABLE 43 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 44 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    7.2.1.1 Transvenous ICDs
                                TABLE 45 TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 46 TRANSVENOUS ICDS MARKET, BY REGION, 2022–2029 (USD MILLION)
                               7.2.1.1.1 Biventricular ICDS/CRT-Ds
                                             7.2.1.1.1.1 Greater preference in heart failure patients to drive market
                                                              TABLE 47 BIVENTRICULAR ICDS/CRT-DS MARKET, BY REGION, 2022–2029 (USD MILLION)
                               7.2.1.1.2 Dual-chamber ICDs
                                             7.2.1.1.2.1 Higher diagnostic accuracy to support usage
                                                              TABLE 48 DUAL-CHAMBER ICDS MARKET, BY REGION, 2022–2029 (USD MILLION)
                               7.2.1.1.3 Single-chamber ICDs
                                             7.2.1.1.3.1 Launch of MRI-compatible single-chamber ICDs to support market growth
                                                              TABLE 49 SINGLE-CHAMBER ICDS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    7.2.1.2 Subcutaneous ICDs
                               7.2.1.2.1 Safety and efficacy of S-ICDs to boost adoption
                                              TABLE 50 SUBCUTANEOUS ICDS MARKET, BY REGION, 2022–2029 (USD MILLION)
           7.2.2 EXTERNAL DEFIBRILLATORS
                    TABLE 51 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 52 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    7.2.2.1 Automated external defibrillators
                                TABLE 53 INDICATIVE LIST OF AEDS THAT HAVE RECEIVED US FDA PRE-MARKET APPROVAL (2018–2022)
                                TABLE 54 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 55 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                               7.2.2.1.1 Semi-automated external defibrillators
                                             7.2.2.1.1.1 Semi-automated external defibrillators to hold largest market share
                                                               TABLE 56 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                               7.2.2.1.2 Fully automated external defibrillators
                                             7.2.2.1.2.1 Benefits of fully automatic AEDs and higher accuracy to drive market
                                                               TABLE 57 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    7.2.2.2 Manual external defibrillators
                               7.2.2.2.1 North America to dominate manual defibrillators market
                                              TABLE 58 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    7.2.2.3 Wearable cardioverter defibrillators
                               7.2.2.3.1 Ease of use and noninvasive nature to support market growth
                                              TABLE 59 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
    7.3 PACEMAKERS 
          TABLE 60 PACEMAKERS MARKET, BY REGION, 2022–2029 (USD MILLION)
           7.3.1 PACEMAKERS MARKET, BY IMPLANTABILITY
                    TABLE 61 PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                    7.3.1.1 Implantable pacemakers
                               7.3.1.1.1 Introduction of leadless and MRI-safe devices to boost adoption
                                              TABLE 62 IMPLANTABLE PACEMAKERS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    7.3.1.2 External pacemakers
                               7.3.1.2.1 Increasing number of open-heart surgeries to drive demand
                                              TABLE 63 EXTERNAL PACEMAKERS MARKET, BY REGION, 2022–2029 (USD MILLION)
           7.3.2 PACEMAKERS MARKET, BY TYPE
                    TABLE 64 PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    7.3.2.1 Biventricular/CRT-Ps
                               7.3.2.1.1 High cost and unfavorable reimbursement to hinder growth
                                              TABLE 65 BIVENTRICULAR/CRT-PS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    7.3.2.2 Dual-chamber pacemakers
                               7.3.2.2.1 Dual-chamber pacemakers to witness high demand due to widespread usage
                                              TABLE 66 DUAL-CHAMBER PACEMAKERS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    7.3.2.3 Single-chamber pacemakers
                               7.3.2.3.1 Introduction of leadless pacemakers to stimulate demand
                                              TABLE 67 SINGLE-CHAMBER PACEMAKERS MARKET, BY REGION, 2022–2029 (USD MILLION)
 
8 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE (Page No. - 127)
    8.1 INTRODUCTION 
          TABLE 68 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
    8.2 INVASIVE PROCEDURES 
           8.2.1 GROWING NUMBER OF CARDIAC PROCEDURES TO DRIVE MARKET GROWTH
                    TABLE 69 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR INVASIVE PROCEDURES, BY REGION, 2022–2029 (USD MILLION)
    8.3 NON-INVASIVE PROCEDURES 
           8.3.1 GROWING PREVALENCE OF LIFESTYLE AND GENETIC DISEASES TO PROPEL ADOPTION
                    TABLE 70 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR NON-INVASIVE PROCEDURES, BY REGION, 2022–2029 (USD MILLION)
 
9 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION (Page No. - 130)
    9.1 INTRODUCTION 
          TABLE 71 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
    9.2 ARRHYTHMIAS 
           9.2.1 GROWING NUMBER OF ATRIAL FIBRILLATION CASES TO DRIVE MARKET
          vTABLE 72 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR ARRHYTHMIAS, BY REGION, 2022–2029 (USD MILLION)
    9.3 MYOCARDIAL INFARCTION 
           9.3.1 RISING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
                    TABLE 73 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR MYOCARDIAL INFARCTION, 2022–2029 (USD MILLION)
    9.4 HEART FAILURE 
           9.4.1 GROWING AGING POPULATION TO DRIVE PREVALENCE OF HEART FAILURE
                    TABLE 74 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HEART FAILURE, BY REGION, 2022–2029 (USD MILLION)
    9.5 OTHER APPLICATIONS 
          TABLE 75 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
 
10 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER (Page No. - 135)
     10.1 INTRODUCTION 
             TABLE 76 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
     10.2 HOSPITALS 
             10.2.1 RISING NUMBER OF CARDIAC IMPLANT PROCEDURES TO DRIVE MARKET
                        TABLE 77 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION)
     10.3 CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS 
             10.3.1 GROWING FOCUS ON AMBULATORY CARE IN US TO PROPEL DEVICE ADOPTION
                        TABLE 78 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2022–2029 (USD MILLION)
     10.4 OTHER END USERS 
             TABLE 79 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
 
11 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION (Page No. - 139)
     11.1 INTRODUCTION 
             TABLE 80 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
             TABLE 81 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
             TABLE 82 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
     11.2 NORTH AMERICA 
             11.2.1 NORTH AMERICA: RECESSION IMPACT
                        FIGURE 30 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT
                        TABLE 83 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 84 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 85 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 86 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 87 NORTH AMERICA: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 88 NORTH AMERICA: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 89 NORTH AMERICA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 90 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 91 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 92 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 93 NORTH AMERICA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 94 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 95 NORTH AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 96 NORTH AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                        TABLE 97 NORTH AMERICA: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 98 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 99 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                        TABLE 100 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.2.2 US
                        11.2.2.1 US to hold largest market share in North America
                                      TABLE 101 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 102 US: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 103 US: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 104 US: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 105 US: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 106 US: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 107 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 108 US: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 109 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 110 US: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 111 US: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                                      TABLE 112 US: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 113 US: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 114 US: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                                      TABLE 115 US: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.2.3 CANADA
                        11.2.3.1 Growing funding for research to drive market
                                      TABLE 116 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 117 CANADA: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 118 CANADA: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 119 CANADA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 120 CANADA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 121 CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 122 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 123 CANADA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 124 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 125 CANADA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 126 CANADA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                                      TABLE 127 CANADA: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 128 CANADA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 129 CANADA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                                      TABLE 130 CANADA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
     11.3 EUROPE 
             11.3.1 EUROPE: RECESSION IMPACT
                        TABLE 131 EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 132 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 133 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 134 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 135 EUROPE: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 136 EUROPE: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 137 EUROPE: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 138 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 139 EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 140 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 141 EUROPE: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 142 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 143 EUROPE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 144 EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                        TABLE 145 EUROPE: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 146 EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 147 EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                        TABLE 148 EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.2 GERMANY
                        11.3.2.1 Increasing healthcare expenditure to drive market growth
                                      TABLE 149 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 150 GERMANY: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 151 GERMANY: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 152 GERMANY: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 153 GERMANY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 154 GERMANY: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 155 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 156 GERMANY: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 157 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 158 GERMANY: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 159 GERMANY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                                      TABLE 160 GERMANY: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 161 GERMANY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 162 GERMANY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                                      TABLE 163 GERMANY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 Rising prevalence of heart failure to boost adoption of CRT devices
                                      TABLE 164 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 165 FRANCE: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 166 FRANCE: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 167 FRANCE: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 168 FRANCE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 169 FRANCE: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 170 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 171 FRANCE: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 172 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 173 FRANCE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 174 FRANCE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                                      TABLE 175 FRANCE: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 176 FRANCE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 177 FRANCE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                                      TABLE 178 FRANCE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.4 UK
                        11.3.4.1 Rising demand for home-based cardiac monitoring devices to support market growth
                                      TABLE 179 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 180 UK: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 181 UK: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 182 UK: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 183 UK: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 184 UK: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 185 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 186 UK: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 187 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 188 UK: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 189 UK: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                                      TABLE 190 UK: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 191 UK: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 192 UK: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                                      TABLE 193 UK: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.5 ITALY
                        11.3.5.1 Increasing incidence of atrial fibrillation to drive market
                                      TABLE 194 ITALY: NUMBER OF ELDERLY CITIZENS WITH ATRIAL FIBRILLATION (THOUSANDS)
                                      TABLE 195 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 196 ITALY: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 197 ITALY: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 198 ITALY: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 199 ITALY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 200 ITALY: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 201 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 202 ITALY: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 203 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 204 ITALY: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 205 ITALY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                                      TABLE 206 ITALY: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 207 ITALY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 208 ITALY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                                      TABLE 209 ITALY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.6 SPAIN
                        11.3.6.1 Rising awareness and growing device adoption to support market growth
                                      TABLE 210 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 211 SPAIN: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 212 SPAIN: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 213 SPAIN: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 214 SPAIN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 215 SPAIN: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 216 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 217 SPAIN: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 218 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 219 SPAIN: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 220 SPAIN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                                      TABLE 221 SPAIN: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 222 SPAIN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 223 SPAIN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                                      TABLE 224 SPAIN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.7 REST OF EUROPE
                        TABLE 225 PERCENTAGE OF POPULATION AGED 60 YEARS OR OVER, 2029 VS. 2050
                        TABLE 226 REST OF EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 227 REST OF EUROPE: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 228 REST OF EUROPE: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 229 REST OF EUROPE: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 230 REST OF EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 231 REST OF EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 232 REST OF EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 233 REST OF EUROPE: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 234 REST OF EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 235 REST OF EUROPE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 236 REST OF EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                        TABLE 237 REST OF EUROPE: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 238 REST OF EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 239 REST OF EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                        TABLE 240 REST OF EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
     11.4 ASIA PACIFIC 
             11.4.1 ASIA PACIFIC: RECESSION IMPACT
                        FIGURE 31 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT
                        TABLE 241 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 242 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 243 ASIA PACIFIC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 244 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 245 ASIA PACIFIC: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 246 ASIA PACIFIC: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 247 ASIA PACIFIC: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 248 ASIA PACIFIC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 249 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 250 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 251 ASIA PACIFIC: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 252 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 253 ASIA PACIFIC: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 254 ASIA PACIFIC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                        TABLE 255 ASIA PACIFIC: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 256 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 257 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                        TABLE 258 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.4.2 JAPAN
                        11.4.2.1 High healthcare expenditure and favorable reimbursement & insurance policies to support market growth
                                      TABLE 259 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 260 JAPAN: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 261 JAPAN: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 262 JAPAN: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 263 JAPAN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 264 JAPAN: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 265 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 266 JAPAN: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 267 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 268 JAPAN: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 269 JAPAN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                                      TABLE 270 JAPAN: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 271 JAPAN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 272 JAPAN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                                      TABLE 273 JAPAN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.4.3 CHINA
                        11.4.3.1 Rising prevalence of CVDs and government support for infrastructural improvement to drive market
                                      TABLE 274 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 275 CHINA: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 276 CHINA: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 277 CHINA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 278 CHINA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 279 CHINA: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 280 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 281 CHINA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 282 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 283 CHINA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 284 CHINA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                                      TABLE 285 CHINA: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 286 CHINA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 287 CHINA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                                      TABLE 288 CHINA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.4.4 INDIA
                        11.4.4.1 Increasing incidence of CVD to propel market growth
                                      TABLE 289 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 290 INDIA: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 291 INDIA: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 292 INDIA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 293 INDIA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 294 INDIA: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 295 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 296 INDIA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 297 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 298 INDIA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 299 INDIA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                                      TABLE 300 INDIA: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 301 INDIA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 302 INDIA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                                      TABLE 303 INDIA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.4.5 REST OF ASIA PACIFIC
                        TABLE 304 REST OF ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 305 REST OF ASIA PACIFIC: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 306 REST OF ASIA PACIFIC: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 307 REST OF ASIA PACIFIC: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 308 REST OF ASIA PACIFIC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 309 REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 310 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 311 REST OF ASIA PACIFIC: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 312 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 313 REST OF ASIA PACIFIC: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 314 REST OF ASIA PACIFIC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                        TABLE 315 REST OF ASIA PACIFIC: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 316 REST OF ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 317 REST OF ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                        TABLE 318 REST OF ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
     11.5 REST OF THE WORLD 
             11.5.1 REST OF THE WORLD: RECESSION IMPACT
                        TABLE 319 REST OF THE WORLD: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
                        TABLE 320 REST OF THE WORLD: CARDIAC MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
                        TABLE 321 REST OF THE WORLD: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
                        TABLE 322 REST OF THE WORLD: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 323 REST OF THE WORLD: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 324 REST OF THE WORLD: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 325 REST OF THE WORLD: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 326 REST OF THE WORLD: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 327 REST OF THE WORLD: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 328 REST OF THE WORLD: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 329 REST OF THE WORLD: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 330 REST OF THE WORLD: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 331 REST OF THE WORLD: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 332 REST OF THE WORLD: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                        TABLE 333 REST OF THE WORLD: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 334 REST OF THE WORLD: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 335 REST OF THE WORLD: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                        TABLE 336 REST OF THE WORLD: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.5.2 LATIN AMERICA
                        11.5.2.1 Rising patient population and growing disease incidence to support market growth
                                      TABLE 337 LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 338 LATIN AMERICA: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 339 LATIN AMERICA: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 340 LATIN AMERICA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 341 LATIN AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 342 LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 343 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 344 LATIN AMERICA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 345 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 346 LATIN AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 347 LATIN AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                                      TABLE 348 LATIN AMERICA: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 349 LATIN AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 350 LATIN AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                                      TABLE 351 LATIN AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.5.3 MIDDLE EAST & AFRICA
                        11.5.3.1 Prominence of local players and healthcare infrastructural improvements to support growth
                                      TABLE 352 MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 353 MIDDLE EAST & AFRICA: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 354 MIDDLE EAST & AFRICA: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 355 MIDDLE EAST & AFRICA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 356 MIDDLE EAST & AFRICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 357 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 358 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 359 MIDDLE EAST & AFRICA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 360 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 361 MIDDLE EAST & AFRICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 362 MIDDLE EAST & AFRICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                                      TABLE 363 MIDDLE EAST & AFRICA: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 364 MIDDLE EAST & AFRICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 365 MIDDLE EAST & AFRICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                                      TABLE 366 MIDDLE EAST & AFRICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.5.4 GCC COUNTRIES
                        11.5.4.1 Increasing awareness and government initiatives to favor market growth
                                      TABLE 367 GCC COUNTRIES: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 368 GCC COUNTRIES: ECG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 369 GCC COUNTRIES: EVENT MONITORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 370 GCC COUNTRIES: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 371 GCC COUNTRIES: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 372 GCC COUNTRIES: DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 373 GCC COUNTRIES: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 374 GCC COUNTRIES: TRANSVENOUS ICDS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 375 GCC COUNTRIES: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 376 GCC COUNTRIES: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 377 GCC COUNTRIES: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022–2029 (USD MILLION)
                                      TABLE 378 GCC COUNTRIES: PACEMAKERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 379 GCC COUNTRIES: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 380 GCC COUNTRIES: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
                                      TABLE 381 GCC COUNTRIES: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
12 COMPETITIVE LANDSCAPE (Page No. - 249)
     12.1 OVERVIEW 
     12.2 KEY STRATEGIES/RIGHT TO WIN 
             12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
                        TABLE 382 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CARDIAC MONITORING DEVICES & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
     12.3 MARKET SHARE ANALYSIS 
             TABLE 383 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: DEGREE OF COMPETITION
     12.4 REVENUE SHARE ANALYSIS 
             FIGURE 32 REVENUE SHARE ANALYSIS OF KEY PLAYERS
     12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
                        FIGURE 33 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
             12.5.5 COMPANY FOOTPRINT
                        FIGURE 34 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: COMPANY FOOTPRINT
                        TABLE 384 COMPANY FOOTPRINT
                        TABLE 385 PRODUCT FOOTPRINT
                        TABLE 386 REGIONAL FOOTPRINT
     12.6 COMPANY EVALUATION MATRIX: START-UP/SME PLAYERS 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 RESPONSIVE COMPANIES
             12.6.3 DYNAMIC COMPANIES
             12.6.4 STARTING BLOCKS
                        FIGURE 35 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (START-UP/SME PLAYERS), 2023
             12.6.5 COMPETITIVE BENCHMARKING
                        TABLE 387 DETAILED LIST OF KEY START-UPS/SMES IN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
     12.7 VALUATION AND FINANCIAL METRICS OF CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICE VENDORS 
             FIGURE 36 EV/EBITDA OF KEY VENDORS
             FIGURE 37 EV/REV OF KEY VENDORS
             FIGURE 38 BETA (5 YEARS) OF KEY VENDORS
             FIGURE 39 1-YEAR PRICE TOTAL RETURN OF KEY VENDORS
     12.8 COMPETITIVE SCENARIO 
             12.8.1 PRODUCT LAUNCHES & APPROVALS
                        TABLE 388 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2024
             12.8.2 DEALS
                        TABLE 389 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: DEALS, JANUARY 2021–APRIL 2024
     12.9 BRAND/PRODUCT COMPARISON 
 
13 COMPANY PROFILES (Page No. - 264)
     13.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             13.1.1 ABBOTT LABORATORIES
                        TABLE 390 ABBOTT LABORATORIES: COMPANY OVERVIEW
                        FIGURE 40 ABBOTT LABORATORIES: COMPANY SNAPSHOT
                        TABLE 391 ABBOTT LABORATORIES: PRODUCTS OFFERED
                        TABLE 392 ABBOTT LABORATORIES: PRODUCT LAUNCHES (JANUARY 2021–APRIL 2024)
             13.1.2 MEDTRONIC
                        TABLE 393 MEDTRONIC: COMPANY OVERVIEW
                        FIGURE 41 MEDTRONIC: COMPANY SNAPSHOT
                        TABLE 394 MEDTRONIC: PRODUCTS OFFERED
             13.1.3 BOSTON SCIENTIFIC CORPORATION
                        TABLE 395 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
                        FIGURE 42 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
                        TABLE 396 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
                        TABLE 397 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS (JANUARY 2021–APRIL 2024)
             13.1.4 GE HEALTHCARE
                        TABLE 398 GE HEALTHCARE: COMPANY OVERVIEW
                        FIGURE 43 GE HEALTHCARE: COMPANY SNAPSHOT
                        TABLE 399 GE HEALTHCARE: PRODUCTS OFFERED
             13.1.5 KONINKLIJKE PHILIPS N.V.
                        TABLE 400 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
                        FIGURE 44 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
                        TABLE 401 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
                        TABLE 402 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES (JANUARY 2021–APRIL 2024)
             13.1.6 ASAHI KASEI CORPORATION
                        TABLE 403 ASAHI KASEI CORPORATION: COMPANY OVERVIEW
                        FIGURE 45 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
                        TABLE 404 ASAHI KASEI CORPORATION: PRODUCTS OFFERED
             13.1.7 MICROPORT SCIENTIFIC CORPORATION
                        TABLE 405 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW
                        FIGURE 46 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
                        TABLE 406 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED
             13.1.8 BAXTER
                        TABLE 407 BAXTER: COMPANY OVERVIEW
                        FIGURE 47 BAXTER: COMPANY SNAPSHOT
                        TABLE 408 BAXTER: PRODUCTS OFFERED
                        TABLE 409 BAXTER: DEALS (JANUARY 2021–APRIL 2024)
             13.1.9 NIHON KOHDEN CORPORATION
                        TABLE 410 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
                        FIGURE 48 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
                        TABLE 411 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED
                        TABLE 412 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES (JANUARY 2021–APRIL 2024)
             13.1.10 BIOTRONIK
                        TABLE 413 BIOTRONIK: COMPANY OVERVIEW
                        TABLE 414 BIOTRONIK: PRODUCTS OFFERED
             13.1.11 SCHILLER
                        TABLE 415 SCHILLER: COMPANY OVERVIEW
                        TABLE 416 SCHILLER: PRODUCTS OFFERED
             13.1.12 ACS DIAGNOSTICS
                        TABLE 417 ACS DIAGNOSTICS: COMPANY OVERVIEW
                        TABLE 418 ACS DIAGNOSTICS: PRODUCTS OFFERED
             13.1.13 BPL MEDICAL TECHNOLOGIES
                        TABLE 419 BPL MEDICAL TECHNOLOGIES: COMPANY OVERVIEW
                        TABLE 420 BPL MEDICAL TECHNOLOGIES: PRODUCTS OFFERED
             13.1.14 BTL
                        TABLE 421 BTL: COMPANY OVERVIEW
                        TABLE 422 BTL: PRODUCTS OFFERED
             13.1.15 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
                        TABLE 423 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
                        TABLE 424 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED
     13.2 OTHER PLAYERS 
             13.2.1 OSYPKA AG
             13.2.2 ALIVECOR, INC.
             13.2.3 AMIITALIA
             13.2.4 BEXEN CARDIO
             13.2.5 NARANG MEDICAL LIMITED
             13.2.6 PRIMEDIC
             13.2.7 PROGETTI
             13.2.8 INNOMED MEDICAL INC.
             13.2.9 LUMED SRL
             13.2.10 NASIFF ASSOCIATES INC.
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
14 APPENDIX (Page No. - 303)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS 

The study involved four major activities in estimating the current size of the cardiac monitoring & cardiac rhythm management devices Market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (Cardiologist, Surgeons, Cardiac consultant) and supply sides (cardiac monitoring & cardiac rhythm management devices providers and distributors).

The following is a breakdown of the primary respondents:

Breakdown of Primary Participants:

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size, and Share

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2. Tiers of companies are defined based on their total revenue. As of 2021: Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the cardiac monitoring & cardiac rhythm management devices Market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the cardiac monitoring & cardiac rhythm management devices industry.

MARKET DEFINITION

Cardiac monitoring refers to the continuous monitoring of heart activities by cardiac monitoring devices such as electrocardiograms, recording devices, and visual/audible recorders. These devices are used to identify or rule out a heart rhythm disorder and determine the right course of treatment.

Cardiac rhythm management devices include implantable devices (defibrillators and pacemakers), leads, and external devices to treat and manage arrhythmia-related diseases. The major end users of implantable pacemakers and defibrillators are hospitals, cardiac centers, clinics, and ambulatory surgery centers.

MARKET STAKEHOLDERS

  • Government and academic institutes
  • Research laboratories, diagnostic centers, and research institutes.
  • Cardiac monitoring and cardiac rhythm management device manufacturers
  • Suppliers and distributors
  • Monitoring service providers
  • Healthcare service providers
  • Physicians
  • Diagnostic centers
  • Health insurance players
  • Research and consulting firms.

Report Objectives

  • To define, describe, and forecast the global cardiac monitoring & cardiac rhythm management devices Market based on Type, Application, Procedure, End User, and Region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)   
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the cardiac monitoring & cardiac rhythm management devices Market.

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company
  • Geographic Analysis:  Further breakdown of the European cardiac monitoring & cardiac rhythm management devices Market into specific countries.
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 1038
Published ON
May, 2024
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
Latest News
READ MORE
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback